• About
  • Advertise
  • Careers
  • Write for us
  • Contact
  • Terms of service
No Result
View All Result
Saturday, February 27, 2021
THE MILLENNIAL SOURCE
  • World
  • US
  • Asia
  • Politics
  • Business
  • Profiles
  • Lifestyle
    • Food & Travel
    • Tech & Money
    • Health
    • Entertainment
  • Newsletter
TMS
No Result
View All Result
Home WORLD

FDA revokes emergency authorization of hydroxychloroquine for COVID-19 treatment

byAnanta Agarwal
June 16, 2020
in WORLD
Reading Time: 3 minute read
FDA revokes emergency authorization of hydroxychloroquine for COVID-19 treatment

Source: Dicardiology

Share on FacebookShare on TwitterShare on Linkedin



On Monday the United States Food and Drug Administration (FDA) rescinded its emergency authorization of anti-malarial drug hydroxychloroquine, the drug that has been repeatedly endorsed by President Donald Trump as an effective COVID-19 treatment.

“FDA has concluded that, based on this new information and other information discussed in the attached memorandum, it is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating COVID-19, nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risks,” FDA Chief Scientist Denise Hinton wrote in a letter to Gary Disbrow, the acting president of the Biomedical Advanced Research and Development Authority (BARDA) on Monday.

On the same day, the FDA also warned against the administration of the drug to patients taking remdesivir, an antiviral drug by Gilead Sciences Inc. that has received authorization for treatment of COVID-19. The statement explained that the combination of the two drugs could reduce the effectiveness of remdesivir.

“The agency is not aware of instances of this reduced activity occurring in the clinical setting but is continuing to evaluate all data related to remdesivir,” the FDA said.

The FDA’s recent decision will not affect clinical trials of hydroxychloroquine.

Hydroxychloroquine first gained attention in February when small and non-peer reviewed reports from China suggested that it could be a potential treatment for COVID-19. Prior to this report, it was the 128th most commonly prescribed medication in the US, with more than five million prescriptions in 2017. 

The FDA issued authorization for the drug on March 28 to treat patients hospitalized with COVID-19 and on April 13, Trump announced that 29 million doses of the drug had been deployed by his administration. 

However, on April 24, the FDA warned doctors against prescribing the drug to patients outside of clinical trials, citing reports of “serious heart rhythm problems” in patients who had taken the drug. 

Despite the FDA’s warnings, Trump continued to promote the drug and in mid-May, claimed that he had been taking hydroxychloroquine as a preventive measure after two of his aides had fallen ill with the virus.

The FDA’s announcement also comes amid recent studies that have shown hydroxychloroquine to be ineffective in treating COVID-19.

A study conducted in the United Kingdom early this month found no evidence of the drug’s ability to treat COVID-19 patients. Another trial conducted by the University of Minnesota also concluded that the drug did not prevent healthy individuals from contracting the virus after coming in contact with a COVID-19 positive patient. 

Hydroxychloroquine will continue to be prescribed to patients for malaria, lupus and rheumatoid arthritis – illnesses for which the drug has approval.

Have a tip or story? Get in touch with our reporters at [email protected]

Like TMS? Subscribe to our free daily newsletter

Related

Tags: North AmericaShort read
ShareTweetShare

Latest Posts

Everything you need to know about cryptocurrency

Everything you need to know about cryptocurrency

February 25, 2021
Will Biden follow the Trump administration’s plan to withdraw troops from Afghanistan?

Will Biden follow the Trump administration’s plan to withdraw troops from Afghanistan?

February 25, 2021
What are SPACs?

What are SPACs?

February 25, 2021

Where do the US and Iran stand with the JCPOA agreement?

February 24, 2021

500,000 US COVID-19 deaths is far higher than previously predicted. What were the initial projections?

February 23, 2021

Reddit’s popularity is at an all-time high. Is an IPO next?

February 23, 2021

COVID-19 numbers are declining in the US and countries around the world

February 23, 2021

Recidivism rates for Black men in the US prison system are higher than all other groups

February 22, 2021

Where is marijuana legalization now?

February 22, 2021
  • About
  • Advertise
  • Careers
  • Write for us
  • Contact
  • Terms of service

© 2020 The Millennial Source Ltd.

No Result
View All Result
  • World
  • US
  • Asia
  • Politics
  • Business
  • Profiles
  • Lifestyle
    • Food & Travel
    • Tech & Money
    • Health
    • Entertainment
  • Newsletter

© 2020 The Millennial Source Ltd.

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

The Millennial Source
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.